News that distribution of the Johnson and Johnson vaccine is being paused is another blow to Europe’s vaccination programme and reinforces our view that the euro-zone economy is unlikely to begin a sustained recovery until Q3. Next week, all eyes will be on the ECB and Christine Lagarde’s attempts to explain why the Bank failed to deliver on its promise to “significantly” step up its asset purchases over the past few weeks.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to gain:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services